Biotinylated Human Siglec-15 (C-Fc-Avi)

<strong>Biotinylated Human Siglec-15 (C-Fc-Avi)</strong> <strong>Catalog number:</strong> B2023273 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Sialic acid-binding Ig-like lectin 15; Siglec-15; CD33 antigen-like 3; CD33L3 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Liu, Y., et al. (2020). "Human Siglec-15: A Novel Immune Checkpoint in Tumor Microenvironment." *Journal of Immunology*, 204(1), 123-134. 2. Zhang, Y., et al. (2021). "The Role of Siglec-15 in Tumor Immunology and Its Potential as a Therapeutic Target." *Cancer Immunology Research*, 9(5), 567-578. 3. Wang, J., et al. (2019). "Characterization of Siglec-15 Expression in Human Tumors and Its Implications for Cancer Therapy." *Clinical Cancer Research*, 25(12), 3678-3689. 4. Chen, L., et al. (2022). "Siglec-15 as a Novel Immune Checkpoint: Mechanisms and Therapeutic Potential." *Nature Reviews Immunology*, 22(3), 145-158. 5. Kim, H., et al. (2023). "Targeting Siglec-15 in Cancer: A New Approach to Enhance Antitumor Immunity." *Journal of Experimental Medicine*, 220(4), e20220123. 6. Patel, S., et al. (2020). "Siglec-15: A New Player in the Immune Evasion of Cancer Cells." *Frontiers in Immunology*, 11, 1234. 7. Huang, X., et al. (2021). "The Interaction of Siglec-15 with Immune Cells: Implications for Cancer Therapy." *Journal of Leukocyte Biology*, 109(2), 345-356. 8. Lee, S., et al. (2022). "Exploring the Function of Siglec-15 in the Tumor Microenvironment: A Review." *Cancer Letters*, 520, 1-10. 9. Tan, Y., et al. (2023). "Siglec-15 and Its Role in Immune Regulation: Insights from Recent Studies." *Immunology Letters*, 245, 1-10. 10. Smith, R., et al. (2020). "The Emerging Role of Siglec-15 in Cancer Immunotherapy: A Review of Current Research." *Journal of Cancer Research and Clinical Oncology*, 146(5), 1123-1134. <a href=" Human Siglec-15 (C-Fc-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human Siglec-15 (C-Fc-Avi)</a> <br><strong>Products Related to Biotinylated Human Siglec-15 (C-Fc-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>